BMRN

BioMarin Pharmaceutical Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$55.50

Market Cap

$10.67B

Beta

0.29

P/E

32.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+12.87%

EPS Growth (YoY)-18.18%

Revenue CAGR 3Y+15.40%

P/E Ratio32.0

PEG Ratio—

FCF Yield+6.79%

Debt / Equity0.11

Interest Coverage48.9x

No credit card required

Already have an account? Sign in to view the full analysis for BMRN.